Global Autoimmune Disease Diagnostics Market Size, Share and COVID-19 Impact Analysis By Type (Systemic Autoimmune Disease [Rheumatoid Arthritis, Psoriasis, Systemic Lupus Erythematosus (SLE), Multiple Sclerosis, Other Systemic Autoimmune Diseases and Localized Autoimmune Disease Inflammatory Bowel Disease, Type 1 Diabetes, Thyroid, and Other Localized Autoimmune Diseases]), By Diagnosis Type (Antinuclear Antibody Tests, Autoantibody Tests, Complete Blood Count (CBC), C-reactive Protein (CRP), Urinalysis and Others tests), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2021 – 2030.

Industry: Healthcare
RELEASE DATE Oct 2022
REPORT ID SI1187
PAGES 190
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis By Type
      2. Market Attractiveness Analysis By Diagnosis Type
      3. Market Attractiveness Analysis By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1.   Advancement in Screening and Diagnosis Procedures
    3. Restraints
      1.   lack of experienced specialists
    4. Opportunities
      1.   Adoption of Advanced Therapeutics
    5. Challenges

5.5.1. Increasing Treatment Costs

  1. Global Autoimmune Disease Diagnostics Market Analysis and Projection, By Type
    1. Segment Overview
    2. Systemic Autoimmune Disease  
    3. Localized Autoimmune Disease
  2. Global Autoimmune Disease Diagnostics Market Analysis and Projection, By Diagnosis Type
    1.  Segment Overview
    2.  Antinuclear Antibody Tests
    3. Autoantibody Tests
    4.  Complete Blood Count (CBC)
    5.  C-reactive Protein (CRP)
    6. Urinalysis
  3. Global Autoimmune Disease Diagnostics Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  4. Global Autoimmune Disease Diagnostics Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Autoimmune Disease Diagnostics Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  5. Company Profiles
    1.  Siemens AG
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
    2.  SWOT Analysis
  6.  Abbott
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  7.  Thermo Fisher Scientific Inc.
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  8.  Danaher
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  9.  GRIFOLS
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  10.  Bio-Rad Laboratories Inc.
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  11.  Protagen AG
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  12.  HYCOR
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  13.  Nova Diagnostics
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  14.   Trinity Biotech
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  15.  EUROIMMUN AG
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  16.  Quest Diagnostics
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  17.  Hemagen Diagnostics Inc.
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  18.  Crescendo Bioscience Inc.
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  19.  AESKU GROUP GmbH
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  20.  AESKU GROUP GmbH
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  21.  Seramun Diagnostica GmbH.
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  22.  Myriad Genetics Inc.
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  23.  Omega Diagnostics Group PLC
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  24.  ORGENTEC DIagnostika
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis

List of Table

  1. Global Autoimmune Disease Diagnostics Market, By Type, 2022-2030(USD Billion)
  2. Global Systemic Autoimmune Disease, Autoimmune Disease Diagnostics Market, By Region, 2022-2030(USD Billion)
  3. Global Localized Autoimmune Disease, Autoimmune Disease Diagnostics Market, By Region, 2022-2030(USD Billion)
  4. Global Autoimmune Disease Diagnostics Market, By Diagnosis Type, 2022-2030(USD Billion)
  5. Global Antinuclear Antibody Tests, Autoimmune Disease Diagnostics Market, By Region 2022-2030(USD Billion)
  6. Global Autoantibody Tests, Autoimmune Disease Diagnostics Market, By Region, 2022-2030(USD Billion)
  7. Global Complete Blood Count (CBC), Autoimmune Disease Diagnostics Market, By Region, 2022-2030(USD Billion)
  8. Global C-reactive Protein (CRP), Autoimmune Disease Diagnostics Market, By Region, 2022-2030(USD Billion)
  9. Global Urinalysis, Autoimmune Disease Diagnostics Market, By Region, 2022-2030(USD Billion)
  10. Global Others tests, Autoimmune Disease Diagnostics Market, By Region, 2022-2030(USD Billion)
  11. Global Autoimmune Disease Diagnostics Market, By Region, 2022-2030(USD Billion)
  12. North America Autoimmune Disease Diagnostics Market, By Type, 2022-2030(USD Billion)
  13. North America Autoimmune Disease Diagnostics Market, By Diagnosis Type, 2022-2030(USD Billion)
  14. U.S. Autoimmune Disease Diagnostics Market, By Type, 2022-2030(USD Billion)
  15. U.S. Autoimmune Disease Diagnostics Market, By Diagnosis Type, 2022-2030(USD Billion)  
  16. Canada Autoimmune Disease Diagnostics Market, By Type, 2022-2030(USD Billion)
  17. Canada Autoimmune Disease Diagnostics Market, By Diagnosis Type, 2022-2030(USD Billion)
  18. Mexico Autoimmune Disease Diagnostics Market, By Type, 2022-2030(USD Billion)
  19. Mexico Autoimmune Disease Diagnostics Market, By Diagnosis Type, 2022-2030(USD Billion)
  20. Europe Autoimmune Disease Diagnostics Market, By Type, 2022-2030(USD Billion)
  21. Europe Autoimmune Disease Diagnostics Market, By Diagnosis Type, 2022-2030(USD Billion)
  22. Germany Autoimmune Disease Diagnostics Market, By Type, 2022-2030(USD Billion)
  23. Germany Autoimmune Disease Diagnostics Market, By Diagnosis Type, 2022-2030(USD Billion)
  24. France Autoimmune Disease Diagnostics Market, By Type, 2022-2030(USD Billion)
  25. France Autoimmune Disease Diagnostics Market, By Diagnosis Type, 2022-2030(USD Billion)
  26. U.K. Autoimmune Disease Diagnostics Market, By Type, 2022-2030(USD Billion)
  27. U.K. Autoimmune Disease Diagnostics Market, By Diagnosis Type, 2022-2030(USD Billion)
  28. Italy Autoimmune Disease Diagnostics Market, By Type, 2022-2030(USD Billion)
  29. Italy Autoimmune Disease Diagnostics Market, By Diagnosis Type, 2022-2030(USD Billion)
  30. Spain Autoimmune Disease Diagnostics Market, By Type, 2022-2030(USD Billion)
  31. Spain Autoimmune Disease Diagnostics Market, By Diagnosis Type, 2022-2030(USD Billion)
  32. Asia Pacific Autoimmune Disease Diagnostics Market, By Type, 2022-2030(USD Billion)
  33. Asia Pacific Autoimmune Disease Diagnostics Market, By Diagnosis Type, 2022-2030(USD Billion)
  34. Japan Autoimmune Disease Diagnostics Market, By Type, 2022-2030(USD Billion)
  35. Japan Autoimmune Disease Diagnostics Market, By Diagnosis Type, 2022-2030(USD Billion)
  36. China Autoimmune Disease Diagnostics Market, By Type, 2022-2030(USD Billion)
  37. China Autoimmune Disease Diagnostics Market, By Diagnosis Type, 2022-2030(USD Billion)  
  38. India Autoimmune Disease Diagnostics Market, By Type, 2022-2030(USD Billion)
  39. India Autoimmune Disease Diagnostics Market, By Diagnosis Type, 2022-2030(USD Billion)
  40. South America Autoimmune Disease Diagnostics Market, By Type, 2022-2030(USD Billion)
  41. South America Autoimmune Disease Diagnostics Market, By Diagnosis Type, 2022-2030(USD Billion)   
  42. Brazil Autoimmune Disease Diagnostics Market, By Type, 2022-2030(USD Billion)
  43. Brazil Autoimmune Disease Diagnostics Market, By Diagnosis Type, 2022-2030(USD Billion)
  44. The Middle East and Africa Autoimmune Disease Diagnostics Market, By Type, 2022-2030(USD Billion)
  45. The Middle East and Africa Autoimmune Disease Diagnostics Market, By Diagnosis Type, 2022-2030(USD Billion)  
  46. UAE Autoimmune Disease Diagnostics Market, By Type, 2022-2030(USD Billion)
  47. UAE Autoimmune Disease Diagnostics Market, By Diagnosis Type, 2022-2030(USD Billion)
  48. South Africa Autoimmune Disease Diagnostics Market, By Type, 2022-2030(USD Billion)
  49. South Africa Autoimmune Disease Diagnostics Market, By Diagnosis Type, 2022-2030(USD Billion)  

 

List of Figures 

  1. Global Autoimmune Disease Diagnostics Market Segmentation
  2. Autoimmune Disease Diagnostics Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Autoimmune Disease Diagnostics Market
  9. Top Winning Strategies, 2022-2030
  10. Top Winning Strategies, By Development, 2022-2030(%)
  11. Top Winning Strategies, By Company, 2022-2030
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2022
  18. Market Share Analysis, 2022
  19. Restraint and Drivers: Autoimmune Disease Diagnostics Market
  20. Autoimmune Disease Diagnostics Market Segmentation, By Type
  21. Autoimmune Disease Diagnostics Market For Systemic Autoimmune Disease, By Region, 2022-2030 ($Billion)
  22. Autoimmune Disease Diagnostics Market For Localized Autoimmune Disease, By Region, 2022-2030 ($Billion)
  23. Autoimmune Disease Diagnostics Market Segmentation, By Diagnosis Type
  24. Autoimmune Disease Diagnostics Market For Antinuclear Antibody Tests, By Region, 2022-2030 ($Billion)
  25. Autoimmune Disease Diagnostics Market For Autoantibody Tests, By Region, 2022-2030 ($Billion)
  26. Autoimmune Disease Diagnostics Market For Complete Blood Count (CBC), By Region, 2022-2030 ($Billion)
  27. Autoimmune Disease Diagnostics Market For C-reactive Protein (CRP), By Region, 2022-2030 ($Billion)
  28. Autoimmune Disease Diagnostics Market For Urinalysis, By Region, 2022-2030 ($Billion)
  29. Autoimmune Disease Diagnostics Market For Others tests, By Region, 2022-2030 ($Billion)
  30. Procter & Gamble: Net Sales, 2022-2030 ($Billion)
  31. Procter & Gamble: Revenue Share, By Segment, 2022 (%)
  32. Procter & Gamble: Revenue Share, By Region, 2022 (%)
  33. PHYTOMER: Net Sales, 2022-2030 ($Billion)
  34. PHYTOMER: Revenue Share, By Segment, 2022 (%)
  35. PHYTOMER: Revenue Share, By Region, 2022 (%)
  36. Deka Corporation: Net Sales, 2022-2030 ($Billion)
  37. Deka Corporation: Revenue Share, By Segment, 2022 (%)
  38. Deka Corporation: Revenue Share, By Region, 2022 (%)
  39. Johnson & Johnson: Net Sales, 2022-2030 ($Billion)
  40. Johnson & Johnson: Revenue Share, By Segment, 2022 (%)
  41. Johnson & Johnson: Revenue Share, By Region, 2022 (%)
  42. Unilever Plc.: Net Sales, 2022-2030 ($Billion)
  43. Unilever Plc.: Revenue Share, By Segment, 2022 (%)
  44. Unilever Plc.: Revenue Share, By Region, 2022 (%)
  45. Kao Corporation: Net Sales, 2022-2030 ($Billion)
  46. Kao Corporation: Revenue Share, By Segment, 2022 (%)
  47. Kao Corporation: Revenue Share, By Region, 2022 (%)
  48. ZO Skin Health, Inc.: Net Sales, 2022-2030 ($Billion)
  49. ZO Skin Health, Inc.: Revenue Share, By Segment, 2022 (%)
  50. ZO Skin Health, Inc.: Revenue Share, By Region, 2022 (%)
  51. L’Oreal Paris: Net Sales, 2022-2030 ($Billion)
  52. L’Oreal Paris: Revenue Share, By Segment, 2022 (%)
  53. L’Oreal Paris: Revenue Share, By Region, 2022 (%)
  54. Shiseido Company Limited: Net Sales, 2022-2030 ($Billion)
  55. Shiseido Company Limited: Revenue Share, By Segment, 2022 (%)
  56. Shiseido Company Limited: Revenue Share, By Region, 2022 (%)
  57. Estee Lauder Companies, Inc.: Net Sales, 2022-2030 ($Billion)
  58. Estee Lauder Companies, Inc.: Revenue Share, By Segment, 2022 (%)
  59. Estee Lauder Companies, Inc.: Revenue Share, By Region, 2022 (%)

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2021
Tables & Figures:108
Pages:190
Countries covered:16
Companies covered::20
Forecast CAGR:9%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies